TrialCephalalgia : an international journal of headache2022

Time course of efficacy of atogepant for the preventive treatment of migraine: Results from the randomized, double-blind ADVANCE trial.

Todd J Schwedt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.